Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$793K Buy
64,800
+52,800
+440% +$933K 0.01% 1318
2017
Q2
$219K Hold
12,000
﹤0.01% 2159
2017
Q1
$254K Buy
+12,000
New +$234K 0.01% 1752
2016
Q2
Sell
-40,000
Closed -$679K 3421
2016
Q1
$679K Buy
40,000
+20,000
+100% +$334K 0.01% 1356
2015
Q4
$410K Sell
20,000
-38,400
-66% -$799K ﹤0.01% 2051
2015
Q3
$1.25M Buy
58,400
+49,200
+535% +$1.1M 0.01% 1403
2015
Q2
$184K Buy
+9,200
New +$162K ﹤0.01% 2760
2014
Q4
Sell
-23,600
Closed -$236K 4097
2014
Q3
$236K Buy
+23,600
New +$241K ﹤0.01% 3077

Other funds holding DXCM

Spot Trading's DXCM Position: Q3 2017 in Review

Spot Trading increased its DexCom (DXCM) stake by 72% in Q3 2017, buying an estimated $129K and bringing the position to 17,444 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #2192.

Spot Trading first reported a position in DXCM in Q2 2015 and has held it in 7 quarters since. The position peaked at $1.17M in Q2 2016. 275 funds tracked by Wall St. Rank hold DXCM as of Q3 2017.

  • Spot Trading held 17,444 shares of DexCom worth $213K as of Q3 2017.
  • Spot Trading bought 7,316 DexCom shares in Q3 2017, an estimated $129K.
  • DexCom made up ﹤0.01% of Spot Trading's portfolio in Q3 2017, its #2192 holding.
  • Spot Trading first reported a position in DexCom in Q2 2015 and has held it in 7 quarters since.
  • Spot Trading's DexCom position peaked at $1.17M in Q2 2016.
  • 275 funds tracked by Wall St. Rank held DexCom as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.